BackgroundThe prevalence of chronic skin wounds in humans is high, and treatment is often complicated by the presence of pathogenic bacteria. Therefore, safe and innovative treatments to reduce the bacterial load in cutaneous wounds are needed. Mesenchymal stromal cells (MSC) are known to provide paracrine signals that act on resident skin cells to promote wound healing, but their potential antibacterial activities are not well described. The present study was designed to examine the antibacterial properties of MSC from horses, as this animal model offers a readily translatable model for MSC therapies in humans. Specifically, we aimed to (i) evaluate the in vitro effects of equine MSC on the growth of representative gram-negative and gram-positive bacterial species commonly found in skin wounds and (ii) define the mechanisms by which MSC inhibit bacterial growth.MethodsMSC were isolated from the peripheral blood of healthy horses. Gram-negative E. coli and gram-positive S. aureus were cultured in the presence of MSC and MSC conditioned medium (CM), containing all factors secreted by MSC. Bacterial growth was measured by plating bacteria and counting viable colonies or by reading the absorbance of bacterial cultures. Bacterial membrane damage was detected by incorporation of N-phenyl-1-naphthylamine (NPN). Antimicrobial peptide (AMP) gene and protein expression by equine MSC were determined by RT-PCR and Western blot analysis, respectively. Blocking of AMP activity of MSC CM was achieved using AMP-specific antibodies.ResultsWe found that equine MSC and MSC CM inhibit the growth of E. coli and S. aureus, and that MSC CM depolarizes the cell membranes of these bacteria. In addition, we found that equine MSC CM contains AMPs, and blocking these AMPs with antibodies reduces the effects of MSC CM on bacteria.ConclusionsOur results demonstrate that equine MSC inhibit bacterial growth and secrete factors that compromise the membrane integrity of bacteria commonly found in skin wounds. We also identified four specific AMPs produced by equine MSC. The secretion of AMPs may contribute to the value of MSC as a therapy for cutaneous wounds in both horses and humans.
Mechanochromic functionality
realized through force-responsive
molecules (i.e., mechanophores) has great potential for spatially
localized damage warning in polymers. However, in structural plastics,
for which damage warning is most critical, this approach has had minimal
success because brittle failure typically precedes detectable color
change. Herein, we report on the room-temperature mechanochromic activation
of spiropyran in high T
g bisphenol A polycarbonate.
The mechanochromic functionality was introduced by polymerization
of dihydroxyspiropyran as a comonomer while retaining the excellent
thermomechanical properties of the polycarbonate. The mechanochromic
behavior is thoroughly evaluated in response to changes in stress,
deformation, and time, providing new insights regarding how loading
history controls stress accumulation in polymer chains. In addition,
a new method to incorporate mechanochromic functionality in structures
without dispersing costly mechanophores in the bulk is demonstrated
by using a mechanochromic laminate. The room-temperature mechanochromic
activation in a structural polymer combined with the new and efficient
preparation and processing methods bring us closer to the application
of mechanochromic smart materials.
Polymer networks cross-linked by reversible metal-ligand interactions possess versatile mechanical properties achieved simply by varying the metal species and quantity. Although prior experiments have revealed the dependence of the network’s...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.